(Editor’s note: This podcast is from The Not Old – Better Show.)
As part of our Inside Science and Technology interview series, today’s show is an interview with Dr. Pradeep Reddy, a research scientist at the Salk Institute for Biological Studies.
As we all know in the Not Old Better Show audience, aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer’s disease, to name a few. This makes the need for anti-aging therapies all the more urgent. Now, Salk Institute researchers have developed a new gene therapy that is showing promise as a possible way to decelerate the aging process in humans. It uses CRISPR genome-editing technology.
Reddy is a research scientist with a focus on aging, genetics, stem cells and biochemistry. The Salk Institute prioritizes scientific research for cancer, Alzheimer’s disease, aging and other areas of science, and is considered one of the top five research centers in the world.
Next Avenue Editors Also Recommend:
- Will We Soon Be Taking a Pill to Slow Aging?
- Last Year’s Research on Aging Hints at What Lies Ahead
- Is There Such a Thing as Normal Aging?